Synthesis and structure-activity relationship studies of pyrazole-based heterocycles as antitumor agents. 2010

Ahmad M Farag, and Abdelrahman S Mayhoub, and Taha M A Eldebss, and Abdel-Galil E Amr, and Korany A K Ali, and Naglaa A Abdel-Hafez, and Mohamed M Abdulla
Department of Chemistry, Faculty of Science, Cairo University, Giza, Egypt. afarag49@yahoo.com

Several 4-cyano-1,5-diphenylpyrazoles attached to different heterocyclic ring systems at position 3 were synthesized starting from ethyl 4-cyano-1,5-diphenyl-1H-pyrazole-3-carboxylate 1. The newly synthesized compounds were tested in vivo for their anti-estrogenic effects and evaluated in vitro for their cytotoxic properties against estrogen-dependent tumors. 3-(5-Mercapto-1,3,4-oxadiazole-2-yl)-1,5-diphenyl-1H-pyrazole-4-carbonitrile 13 revealed the highest cytotoxic activity with a GI(50) value equal to 40 nM against the IGROVI ovarian tumor cell line. It also showed an anti-estrogen activity 1.6 more effective than the reference drug, in addition to a high tolerable dose. 3-(5-(Methylthio)-4-phenyl-4H-1,2,4-triazol-3-yl)-1,5-diphenyl-1H-pyrazole-4-carbonitrile 7 was found to have the highest anti-estrogenic activity, while 1,5-diphenyl-3-[5-(phenylamino)-1,3,4-thiadiazol-2-yl]-1H-pyrazole-4-carbonitrile 11 showed the lowest activity. The oral LD(50) values revealed that most of the tested compounds are relatively nontoxic.

UI MeSH Term Description Entries
D007928 Lethal Dose 50 The dose amount of poisonous or toxic substance or dose of ionizing radiation required to kill 50% of the tested population. LD50,Dose 50, Lethal
D008297 Male Males
D009570 Nitriles Organic compounds containing the -CN radical. The concept is distinguished from CYANIDES, which denotes inorganic salts of HYDROGEN CYANIDE. Nitrile
D011720 Pyrazoles Azoles of two nitrogens at the 1,2 positions, next to each other, in contrast with IMIDAZOLES in which they are at the 1,3 positions.
D004354 Drug Screening Assays, Antitumor Methods of investigating the effectiveness of anticancer cytotoxic drugs and biologic inhibitors. These include in vitro cell-kill models and cytostatic dye exclusion tests as well as in vivo measurement of tumor growth parameters in laboratory animals. Anticancer Drug Sensitivity Tests,Antitumor Drug Screens,Cancer Drug Tests,Drug Screening Tests, Tumor-Specific,Dye Exclusion Assays, Antitumor,Anti-Cancer Drug Screens,Antitumor Drug Screening Assays,Tumor-Specific Drug Screening Tests,Anti Cancer Drug Screens,Anti-Cancer Drug Screen,Antitumor Drug Screen,Cancer Drug Test,Drug Screen, Anti-Cancer,Drug Screen, Antitumor,Drug Screening Tests, Tumor Specific,Drug Screens, Anti-Cancer,Drug Screens, Antitumor,Drug Test, Cancer,Drug Tests, Cancer,Screen, Anti-Cancer Drug,Screen, Antitumor Drug,Screens, Anti-Cancer Drug,Screens, Antitumor Drug,Test, Cancer Drug,Tests, Cancer Drug,Tumor Specific Drug Screening Tests
D005260 Female Females
D006571 Heterocyclic Compounds Cyclic compounds that include atoms other than carbon in their ring structure. Heterocyclic Compound,Compound, Heterocyclic,Compounds, Heterocyclic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000077289 Letrozole A triazole and benzonitrile derivative that is a selective non-steroidal aromatase inhibitor, similar to ANASTROZOLE. It is used in the treatment of metastatic or locally advanced breast cancer in postmenopausal women. 4,4'-(1H-1,2,4-triazol-1-yl-methylene)-bis(benzonitrile),CGS 20267,CGS-20267,Femara,Fémara,CGS20267
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

Ahmad M Farag, and Abdelrahman S Mayhoub, and Taha M A Eldebss, and Abdel-Galil E Amr, and Korany A K Ali, and Naglaa A Abdel-Hafez, and Mohamed M Abdulla
January 2013, European journal of medicinal chemistry,
Ahmad M Farag, and Abdelrahman S Mayhoub, and Taha M A Eldebss, and Abdel-Galil E Amr, and Korany A K Ali, and Naglaa A Abdel-Hafez, and Mohamed M Abdulla
August 2016, Molecules (Basel, Switzerland),
Ahmad M Farag, and Abdelrahman S Mayhoub, and Taha M A Eldebss, and Abdel-Galil E Amr, and Korany A K Ali, and Naglaa A Abdel-Hafez, and Mohamed M Abdulla
October 2006, Bioorganic & medicinal chemistry,
Ahmad M Farag, and Abdelrahman S Mayhoub, and Taha M A Eldebss, and Abdel-Galil E Amr, and Korany A K Ali, and Naglaa A Abdel-Hafez, and Mohamed M Abdulla
April 1997, Archives of pharmacal research,
Ahmad M Farag, and Abdelrahman S Mayhoub, and Taha M A Eldebss, and Abdel-Galil E Amr, and Korany A K Ali, and Naglaa A Abdel-Hafez, and Mohamed M Abdulla
November 2019, European journal of medicinal chemistry,
Ahmad M Farag, and Abdelrahman S Mayhoub, and Taha M A Eldebss, and Abdel-Galil E Amr, and Korany A K Ali, and Naglaa A Abdel-Hafez, and Mohamed M Abdulla
April 2024, International journal of molecular sciences,
Ahmad M Farag, and Abdelrahman S Mayhoub, and Taha M A Eldebss, and Abdel-Galil E Amr, and Korany A K Ali, and Naglaa A Abdel-Hafez, and Mohamed M Abdulla
April 1998, Archives of pharmacal research,
Ahmad M Farag, and Abdelrahman S Mayhoub, and Taha M A Eldebss, and Abdel-Galil E Amr, and Korany A K Ali, and Naglaa A Abdel-Hafez, and Mohamed M Abdulla
February 2019, Molecular diversity,
Ahmad M Farag, and Abdelrahman S Mayhoub, and Taha M A Eldebss, and Abdel-Galil E Amr, and Korany A K Ali, and Naglaa A Abdel-Hafez, and Mohamed M Abdulla
March 2013, Journal of natural products,
Ahmad M Farag, and Abdelrahman S Mayhoub, and Taha M A Eldebss, and Abdel-Galil E Amr, and Korany A K Ali, and Naglaa A Abdel-Hafez, and Mohamed M Abdulla
October 2021, Journal of agricultural and food chemistry,
Copied contents to your clipboard!